These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23638783)

  • 1. Alzheimer's disease, dementia, mild cognitive impairment and the menopause: a 'window of opportunity'?
    Davey DA
    Womens Health (Lond); 2013 May; 9(3):279-90. PubMed ID: 23638783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Alzheimer's disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy.
    Davey DA
    Neurodegener Dis Manag; 2017 Feb; 7(1):85-94. PubMed ID: 28074678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.
    Brunton S; Pruzin JJ; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
    Postgrad Med; 2023 Jun; 135(5):530-538. PubMed ID: 37219410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of estrogens in the aging brain: dementia and cognitive aging.
    Henderson VW
    Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Decline in Early and Premature Menopause.
    Sochocka M; Karska J; Pszczołowska M; Ochnik M; Fułek M; Fułek K; Kurpas D; Chojdak-Łukasiewicz J; Rosner-Tenerowicz A; Leszek J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist.
    Budson AE; Solomon PR
    Pract Neurol; 2012 Apr; 12(2):88-96. PubMed ID: 22450454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of cerebrospinal fluid (CSF) biomarkers for Alzheimer's type dementia: diagnosis in mild cognitive impairment].
    Verhey FR; Visser PJ
    Ned Tijdschr Geneeskd; 2013; 157(11):A5596. PubMed ID: 23484512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.
    Gopalakrishna G; Brunton S; Pruzin J; Alford S; Hamersky C; Sabharwal A
    BMC Psychiatry; 2023 Oct; 23(1):716. PubMed ID: 37794326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
    Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
    Parnetti L; Chiasserini D; Eusebi P; Giannandrea D; Bellomo G; De Carlo C; Padiglioni C; Mastrocola S; Lisetti V; Calabresi P
    J Alzheimers Dis; 2012; 29(1):229-38. PubMed ID: 22232006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and treatment for Alzheimer's disease: predicting population-level outcomes.
    Furiak NM; Kahle-Wrobleski K; Callahan C; Klein TM; Klein RW; Siemers ER
    Alzheimers Dement; 2012 Jan; 8(1):31-8. PubMed ID: 22265589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton MRS in mild cognitive impairment.
    Kantarci K
    J Magn Reson Imaging; 2013 Apr; 37(4):770-7. PubMed ID: 23526756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there an MCI reversion to cognitively normal? Analysis of Alzheimer's disease biomarkers profiles.
    Park MH; Han C
    Int Psychogeriatr; 2015 Mar; 27(3):429-37. PubMed ID: 25255915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients.
    Scrascia F; Curcio G; Ursini F; Trotta L; Quintiliani L; Migliore S; Altamura C; Pitocco F; Altavilla R; Melgari JM; Quattrocchi CC; Vernieri F
    J Alzheimers Dis; 2014; 38(4):939-50. PubMed ID: 24121958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.